Department of Physical Therapy, Faculty of Nursing and Rehabilitation, Konan Women's University, Kobe 658-0001, Japan.
Department of Rehabilitation, Itami Kousei Neurosurgical Hospital, Itami 664-0028, Japan.
Nutrients. 2021 Oct 13;13(10):3586. doi: 10.3390/nu13103586.
SARC-F is a screening tool for sarcopenia; however, it has not yet been established whether SARC-F scores predict functional outcomes. Therefore, we herein investigated the relationship between SARC-F scores and functional outcomes in stroke patients. The primary outcome in the present study was the modified Rankin Scale (mRS) 3 months after stroke. The relationship between SARC-F scores and poor functional outcomes was examined using a logistic regression analysis. Furthermore, the applicability of SARC-F scores to the assessment of poor functional outcomes was analyzed based on the area under the receiver operating curve (ROC). Eighty-one out of the 324 patients enrolled in the present study (25%) had poor functional outcomes (mRS ≥ 4). The results of the multivariate analysis revealed a correlation between SARC-F scores (OR = 1.29, 95% CI = 1.05-1.59, = 0.02) and poor functional outcomes. A cut-off SARC-F score ≥ 4 had low-to-moderate sensitivity (47.4%) and high specificity (87.3%). The present results suggest that the measurement of pre-stroke SARC-F scores is useful for predicting the outcomes of stroke patients.
SARC-F 是一种肌少症的筛查工具;然而,其评分是否能预测功能结局尚不清楚。因此,我们在此研究了 SARC-F 评分与卒中患者功能结局之间的关系。本研究的主要结局为卒中后 3 个月的改良 Rankin 量表(mRS)评分。采用 logistic 回归分析研究了 SARC-F 评分与不良功能结局之间的关系。此外,还基于受试者工作特征曲线(ROC)下面积分析了 SARC-F 评分对不良功能结局评估的适用性。本研究共纳入 324 例患者,其中 81 例(25%)患者存在不良功能结局(mRS≥4)。多变量分析结果显示,SARC-F 评分与不良功能结局相关(OR=1.29,95%CI=1.05-1.59, =0.02)。SARC-F 评分≥4 的截断值具有较低到中等的敏感性(47.4%)和较高的特异性(87.3%)。本研究结果提示,测量卒中前的 SARC-F 评分有助于预测卒中患者的结局。